Time for Tau? Cognitive Benefit Seen From BIIB080 but Questions Remain

Research evidence excerpt

Time for Tau? Cognitive Benefit Seen From BIIB080 but Questions Remain

Capital IQ.

BMO Capital Markets issues a variety of research products in addition to fundamental research. Institutional clients may request notification

when additional research content is made available on our website. BMO Capital Markets may use proprietary models in the preparation of

reports. Material information about such models may be obtained by contacting the research analyst directly. There is no planned frequency

of model updates.

The analyst(s) named in this report may discuss trading strategies that reference a catalyst or event that may have a near or long term impact

on the market price of the equity securities discussed. In some cases, the impact may directionally counter the analyst’s published 12 month

target price and rating. Any such trading or alternative strategies can be based on differing time horizons, methodologies, or otherwise and are

distinct from and do not affect the analysts' fundamental equity rating in the report.

Research coverage of licensed cannabis producers and other cannabis-related companies is made available only to eligible approved North

American, Australian, and EU-based BMO Nesbitt Burns Inc., BMO Capital Markets Limited, Bank of Montreal Europe Plc and BMO Capital Markets

Corp. clients via email, our website and select third party platforms.

~ Research distribution and approval times are provided on the cover of each report. Times are approximations as system and distribution

processes are not exact and can vary based on the sender and recipients’ services. Unless otherwise noted, times are Eastern Standard and

when two times are provided, the approval time precedes the distribution time.